
Reset all filters
01 3Amneal Pharmaceuticals
02 24AstraZeneca
03 2Lupin Ltd
04 1MSN Laboratories
05 1Par Pharmaceutical
Reset all filters
01 10Antic-calc Tablet, Film Coated
02 4Film Coated Tablet
03 1Saxagliptin + Metformin 2.5 + 1.000Mg 56 Combined Oral Use
04 1Saxagliptin + Metformin 2.5 + 850Mg 56 Combined Oral Use
05 1Saxagliptin 2,5Mg 28 Combined Oral Use
06 1Saxagliptin 5Mg 28 Combined Oral Use
07 2TAB
08 3TABLET, EXTENDED RELEASE;ORAL
09 3TABLET; ORAL
10 1TABLET;ORAL
11 4tablet
Reset all filters
01 2Allowed
02 2Approved
03 2Originator
04 25Blank
Reset all filters
01 1DAPAGLIFLOZIN AND SAXAGLIPTIN
02 2DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE
03 6Komboglyze
04 14Onglyza
05 1Onglyza 2,5
06 1Onglyza 5
07 2Qtern
08 1SAXAGLIPTIN
09 3SAXAGLIPTIN;METFORMIN HYDROCHLORIDE
Reset all filters
01 4Australia
02 4Italy
03 10Norway
04 2South Africa
05 2Sweden
06 2Switzerland
07 7USA
Regulatory Info :
Registration Country : USA
SAXAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : SAXAGLIPTIN;METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG;500MG
Packaging :
Approval Date :
Application Number : 205942
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
SAXAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : SAXAGLIPTIN;METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 2.5MG;1000MG
Packaging :
Approval Date :
Application Number : 205942
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
SAXAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : SAXAGLIPTIN;METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG;1000MG
Packaging :
Approval Date :
Application Number : 205942
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Onglyza
Dosage Form : Saxagliptin 5Mg 28 Combined Oral Use
Dosage Strength : 28 cpr riv 5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Onglyza
Dosage Form : Saxagliptin 2,5Mg 28 Combined Oral Use
Dosage Strength : 28 cpr riv 2.5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Komboglyze
Dosage Form : Saxagliptin + Metformin 2.5 + 850Mg 56 Combined Oral Use
Dosage Strength : 56 cpr riv 2.5 mg + 850 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Komboglyze
Dosage Form : Saxagliptin + Metformin 2.5 + 1.000Mg 56 Combined Oral Use
Dosage Strength : 56 cpr riv 2.5 mg + 1,000 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Onglyza
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 2.5 mg
Packaging : Calendar Gasket
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Onglyza
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 2.5 mg
Packaging : Calendar Gasket
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Onglyza
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 5 mg
Packaging : Calendar Gasket
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Onglyza
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 5 mg
Packaging : Calendar Gasket
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Komboglyze
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 2.5MG; 1000MG
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Komboglyze
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 2.5MG; 1000MG
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Komboglyze
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 2.5MG; 850MG
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Komboglyze
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 2.5MG; 850MG
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Qtern
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 05MG; 10MG
Packaging : Calendar Gasket
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE
Brand Name : DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE
Dosage Form : TABLET; ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 211532
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE
Brand Name : DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE
Dosage Form : TABLET; ORAL
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 211532
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DAPAGLIFLOZIN AND SAXAGLIPTIN
Dosage Form : TABLET; ORAL
Dosage Strength : 10MG/5MG
Packaging :
Approval Date :
Application Number : 211533
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : SAXAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 205959
Regulatory Info :
Registration Country : USA